Latest Safety News

Page 149 of 166
Eskan Company has received conditional approval for C$13.5 million in funding from Canada’s Critical Minerals Infrastructure Fund to advance the Trans-Atikh Project, a key infrastructure initiative supporting lithium development in Quebec’s Eeyou Istchee James Bay region.
Maxwell Dee
Maxwell Dee
10 Feb 2025
CLINUVEL has released preliminary data from its CUV052 study showing SCENESSE® is well tolerated in adolescent erythropoietic protoporphyria (EPP) patients, supporting a planned label extension in 2025.
Victor Sage
Victor Sage
10 Feb 2025
PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.
Ada Torres
Ada Torres
10 Feb 2025
JB Hi-Fi Limited reported a robust 9.8% increase in HY25 sales to AUD 5.67 billion and an 8.0% rise in net profit, supported by its recent acquisition of e&s Trading Co. Despite strong momentum, the company remains cautious about competitive pressures ahead.
Logan Eniac
Logan Eniac
10 Feb 2025
KGL Resources Limited has released a comprehensive feasibility study update for its Jervois Copper Project, confirming its technical robustness and financial viability with plans to commence production in 2027. The project boasts a post-tax net present value of A$405 million and aims to produce around 30,000 tonnes of copper annually, positioning itself to capitalize on a tightening global copper market.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Ansell Limited reports robust FY25 half-year results, driven by strong organic sales and EBIT growth, while accelerating its KBU integration and productivity initiatives.
Ada Torres
Ada Torres
10 Feb 2025
Nyrada has secured ethics approval to begin its first-in-human Phase Ia trial of NYR-BI03, a promising neuro- and cardioprotective drug candidate. Recruitment starts soon, with dosing expected by March and results due in Q3 2025.
Ada Torres
Ada Torres
7 Feb 2025
Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.
Victor Sage
Victor Sage
7 Feb 2025
Lanthanein Resources has completed diamond drilling at its Lady Grey Project, targeting a significant EM conductor plate aligned with gold anomalies. Approval for further drilling under a higher-grade anomaly sets the stage for potential resource expansion.
Maxwell Dee
Maxwell Dee
7 Feb 2025
PARKD has inked a pivotal five-year exclusive licensing agreement with Fielders, a BlueScope Steel division, to commercialise its innovative MDSB® and MDSS® products in Australia and explore international expansion.
Victor Sage
Victor Sage
7 Feb 2025
Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.
Sophie Babbage
Sophie Babbage
7 Feb 2025
Sparc Technologies has secured a fourth trial agreement with BHP Mitsubishi Alliance to test its graphene-enhanced ecosparc® coating in harsh mining conditions, aiming to validate its anti-corrosive performance against market leaders.
Sophie Babbage
Sophie Babbage
7 Feb 2025